Matthew Gordon Varga

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBioprocessing, bioproduction and bioproductsMortalityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 06, 2023
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer.

Carlotta Antoniotti, Alessandra Boccaccino, Robert Seitz

|Feb 22, 2023
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort.

Tyler J Nielsen, Matthew G Varga, Catherine T Cronister

|Mar 06, 2021
Standard Bacteriophage Purification Procedures Cause Loss in Numbers and Activity.

Amanda Carroll-Portillo, Cristina N Coffman, Matthew G Varga

|Aug 29, 2020
Racial Differences in Helicobacter pylori CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States.

Matthew G Varga, Julia Butt, William J Blot

|Jul 28, 2019
Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea.

Julia Butt, Matthew G Varga, Tianyi Wang

Pageof 1